AusPAR: Ezetimibe/ Simvastatin
Related information
- Australian Public Assessment Reports for prescription medicines (AusPARs)
- Browse AusPARs by active ingredient
- Browse AusPARs by product name
- Browse AusPARs by sponsor
How to access a pdf or Word document
*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.
Australian Public Assessment Report
10 April 2013
| AusPAR | |
|---|---|
| Active Ingredient | Ezetimibe/ Simvastatin
|
| Product Name | Vytorin
|
| Sponsor | Merck Sharp & Dohme (Australia) Pty Ltd
|
| Submission Number | PM-2011-01219-3-1
|
| Submission Type | Extension of indications
|
| Decision | Proposed Extension of Indication withdrawn. Revisions to Product Information, including to Dosage and Administration and Clinical Trials sections, approved
|
| AusPAR Date | 28 February 2013
|
| Publication Date | 10 April 2013 |